Molecular (vascular) · PMID 25408528
Molecular aspects of anti-atherosclerotic effects of short peptides — VialBase Research
Class/vascular mechanism context for Vesugen's anti-atherosclerotic claims.
Last updated · 2014 · Khavinson VKh et al. · Bull Exp Biol Med
Key findings
- Short peptides including the vascular Cytogen showed anti-atherosclerotic molecular effects
- Mechanistic support for endothelial/vascular bioregulation
Anti-atherosclerotic effects of short peptides (PMID: 25408528)
Summary
Short peptides of the Khavinson vascular class were associated with anti-atherosclerotic molecular effects, supporting endothelial bioregulation.
Relevance
Mechanistic backing for Vesugen‘s vascular positioning.
See Also
- Parent compound: Vesugen